Athersys Logo

Email this page: News Release

Athersys Announces Results From Phase 2 Study of MultiStem(R) Cell Therapy for Treatment of Ischemic Stroke


Separate multiple addresses with commas. Maximum 200 characters.

These email addresses will be used to email the page on your behalf and will not be used by Athersys for any marketing purposes.


This helps Athersys prevent automated submissions.